TY - JOUR
T1 - Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study
AU - Cook, Lynnette J.
AU - Ho, Luk W.
AU - Wang, Lin
AU - Terrenoire, Edith
AU - Brayne, Carol
AU - Evans, John Grimley
AU - Xuereb, John
AU - Cairns, Nigel J.
AU - Turic, Dragana
AU - Hollingworth, Paul
AU - Moore, Pamela J.
AU - Jehu, Luke
AU - Archer, Nicola
AU - Walter, Sarah
AU - Foy, Catherine
AU - Edmondson, Amanda
AU - Powell, John
AU - Lovestone, Simon
AU - Williams, Julie
AU - Rubinsztein, David C.
PY - 2005/1/5
Y1 - 2005/1/5
N2 - Consistent deficits in the cholinergic system are evident in the brains of Alzheimer's Disease (AD) patients, including reductions in the activities of acetylcholine, acetylcholinesterase (AChE), and choline acetyltransferase (ChAT), increased butyrylcholinesterase (BChE) activity, and a selective loss of nicotinic acetylcholine receptors (nAChRs). Accordingly, we have analyzed polymorphisms in the genes encoding AChE, ChAT, BChE, and several of the subunit genes from neuronal nAChRs, for genetic associations with late-onset AD. A significant association for disease was detected for a non-coding polymorphism in ChAT (allele χ1 2 = 12.84, P = 0.0003; genotype χ2 2 = 11.89, P = 0.0026). Although replication analysis did not confirm the significance of this finding when the replication samples were considered alone (allele χ1 2 = 1.02, P=0.32; genotype χ2 2 = 1.101, P = 0.58) the trends were in the correct direction and a significant association remained when the two sample sets were pooled (allele χ1 2 = 12.37, P = 0.0004; genotype χ2 2 = 11.61, P = 0.003). Previous studies have reported significant disease associations for both the K-variant of BChE and the coding ChAT rs3810950 polymorphism with AD. Replication analyses of these two loci failed to detect any significant association for disease in our case-control samples.
AB - Consistent deficits in the cholinergic system are evident in the brains of Alzheimer's Disease (AD) patients, including reductions in the activities of acetylcholine, acetylcholinesterase (AChE), and choline acetyltransferase (ChAT), increased butyrylcholinesterase (BChE) activity, and a selective loss of nicotinic acetylcholine receptors (nAChRs). Accordingly, we have analyzed polymorphisms in the genes encoding AChE, ChAT, BChE, and several of the subunit genes from neuronal nAChRs, for genetic associations with late-onset AD. A significant association for disease was detected for a non-coding polymorphism in ChAT (allele χ1 2 = 12.84, P = 0.0003; genotype χ2 2 = 11.89, P = 0.0026). Although replication analysis did not confirm the significance of this finding when the replication samples were considered alone (allele χ1 2 = 1.02, P=0.32; genotype χ2 2 = 1.101, P = 0.58) the trends were in the correct direction and a significant association remained when the two sample sets were pooled (allele χ1 2 = 12.37, P = 0.0004; genotype χ2 2 = 11.61, P = 0.003). Previous studies have reported significant disease associations for both the K-variant of BChE and the coding ChAT rs3810950 polymorphism with AD. Replication analyses of these two loci failed to detect any significant association for disease in our case-control samples.
KW - MRC-COGFA
KW - Polymorphism
UR - http://www.scopus.com/inward/record.url?scp=19944429977&partnerID=8YFLogxK
UR - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1552-485X
U2 - 10.1002/ajmg.b.30068
DO - 10.1002/ajmg.b.30068
M3 - Article
C2 - 15690550
AN - SCOPUS:19944429977
VL - 132 B
SP - 5
EP - 8
JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
SN - 1552-4841
IS - 1
ER -